Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor
- Nat Cell Biol. 2017 Oct;19(10):1226-1236. doi: 10.1038/ncb3616.
- 1. Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
- 2. Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
- 3. Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
- 4. Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
- 5. Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA.
- 6. Department of Pediatrics, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA.
- 7. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
- 8. German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.
- 9. Department of Developmental Genetics, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China.
- 10. Center for Regenerative Medicine, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China.
- 11. Cell &Molecular Biology Department, St Jude Children's Hospital, Memphis, Tennessee 38105, USA.
- 12. Immunology Department, St Jude Children's Hospital, Memphis, Tennessee 38105, USA.
- 13. Structural Biology Department, St Jude Children's Hospital, Memphis, Tennessee 38105, USA.
- 14. Chemical Biology and Therapeutics Department, St Jude Children's Hospital, Memphis, Tennessee 38105, USA.
Direct interactions between pro- and anti-apoptotic Bcl-2 Family members form the basis of cell death decision-making at the outer mitochondrial membrane (OMM). Here we report that three anti-apoptotic Bcl-2 proteins (Mcl-1, Bcl-2 and Bcl-xL) found untethered from the OMM function as transcriptional regulators of a prosurvival and growth program. Anti-apoptotic Bcl-2 proteins engage a Bcl-2 homology (BH) domain sequence found in SUFU (suppressor of fused), a tumour suppressor and antagonist of the Gli DNA-binding proteins. Bcl-2 proteins directly promote SUFU turnover, inhibit SUFU-GLI interaction, and induce the expression of the Gli target genes Bcl-2, Mcl-1 and Bcl-xL. Anti-apoptotic Bcl-2 protein/SUFU feedforward signalling promotes Cancer cell survival and growth, and can be disabled with BH3 mimetics-small molecules that target anti-apoptotic Bcl-2 proteins. Our findings delineate a chemical strategy for countering drug resistance in GLI-associated tumours and reveal unanticipated functions for Bcl-2 proteins as transcriptional regulators.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer